معرفی
Trevor Fidler is an Assistant Professor at the University of California San Francisco (UCSF) School of Medicine, where he leads the Fidler Lab in the Cardiovascular Research Institute. His research investigates how hematopoietic cells, particularly macrophages, drive atherosclerosis and cardiovascular disease through mechanisms like clonal hematopoiesis, inflammasome activation, and immune-vascular cell communication.
- Education:
- Postdoctoral Fellow, Molecular Medicine, Columbia University (2023)
- PhD, Pharmacology & Toxicology, University of Utah (2016)
- BS, Biochemistry, New Mexico State University (2010)
Research Interests span Atherosclerosis, Clonal Hematopoiesis, Inflammasome Biology, and Platelet Metabolism. His work explores genetic risk factors, mitochondrial dynamics, and immune cell cross-talk in cardiovascular pathologies.
Recent publications (2024–2017) focus on clonal hematopoiesis, inflammasome modulation, CRISPR-based mechanisms, and glucose metabolism in platelets. Keywords include Cardiovascular Disease, Immunology, and Genetic Risk Modification.
Awards & Honors include finalist for the Irving H. Page Junior Faculty Research Award (2022), winner of the European Vascular Biology Organization publication highlight (2021), and multiple travel awards and best presentation/poster recognitions (2012–2017).
Grants include NIH/NHLBI R00HL157649 (2023–2026) for Mechanisms of Atherogenesis in Clonal Hematopoiesis.
Labs & Teams: The Fidler Lab (UCSF Mission Bay Campus) employs in vivo CRISPR screening, animal models, and collaborations with institutions like Columbia University and University of Iowa to dissect immune-driven atherosclerosis mechanisms.
